Literature DB >> 14682411

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

Enrica Bucchioni1, Sergei A Kharitonov, Luigi Allegra, Peter J Barnes.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation of the respiratory tract.
METHODS: We investigated the presence of interleukin-6 (IL-6: a cytokine secreted by monocytes/macrophages, T cells, B cells, fibroblasts, bone marrow stromal cells, keratinocytes and endothelial cells) in the exhaled breath condensate of 16 exsmokers with moderate COPD, 12 healthy non-smokers. IL-6 was measured by means of a specific enzyme immunoassay.
RESULTS: IL-6 levels were detectable in all of the subjects, but were higher in the COPD patients (8.0 +/- 0.1 pg/ml; P < 0.0001) than in the healthy non-smokers (4.9 +/- 0.2 pg/ml) with a correlation in this group between age and IL-6 levels (r = 0.597; P < 0.05).
CONCLUSIONS: The increased IL-6 levels in exhaled breath condensate may reflect airway inflammation in patients with COPD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682411     DOI: 10.1016/j.rmed.2003.07.008

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  37 in total

Review 1.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 2.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

Review 3.  Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Omar A Minai; Zab Mosenifar
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 4.  Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 5.  The Effect of Ancestry and Genetic Variation on Lung Function Predictions: What Is "Normal" Lung Function in Diverse Human Populations?

Authors:  Victor E Ortega; Rajesh Kumar
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

Review 6.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 7.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

8.  Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body.

Authors:  Siu-Yin Lam; George L Tipoe; Emily C Liong; Man-Lung Fung
Journal:  Histochem Cell Biol       Date:  2008-05-01       Impact factor: 4.304

Review 9.  Biological targets for therapeutic interventions in COPD: clinical potential.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Luca Gallelli; Teresa Renda; Mario Caputi; Rosario Maselli; Serafino A Marsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Clinical use of exhaled biomarkers in COPD.

Authors:  Philip O'Reilly; William Bailey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.